Camp4 Therapeutics (CAMP) Net Cash Flow (2023 - 2026)

Camp4 Therapeutics' Net Cash Flow history runs 4 years deep, the most recent figure standing at -$10.9 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 25.64% year-over-year to -$10.9 million; the TTM figure through Mar 2026 stood at $49.8 million (up 123.38% YoY), while the FY2025 annual figure was $46.0 million, up 79.46% from the prior year.
• Net Cash Flow came in at -$10.9 million for Q1 2026 at Camp4 Therapeutics, down from $34.8 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $61.5 million in Q4 2024 to a low of -$14.7 million in Q1 2025.
• A 4-year average of $4.9 million and a median of -$10.6 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow surged 608.82% in 2024 and plunged 43.37% in 2025, its largest moves.
• Camp4 Therapeutics' Net Cash Flow stood at -$12.1 million in 2023, then soared by 608.82% to $61.5 million in 2024, then slumped by 43.37% to $34.8 million in 2025, then sank by 131.42% to -$10.9 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$10.9 million, $34.8 million, and $36.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison